ResearchMoz

Retinitis Global Clinical Trials Review, Q1, 2011

Publisher Name » GlobalData
Published Date » 2011-01-31
No. Of Pages » N/A


GlobalData's clinical trial report, Retinitis Global Clinical Trials Review, Q1, 2011" provides data on the Retinitis clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Retinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Retinitis). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope
  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy
  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Retinitis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Retinitis 18
Subjects Recruited Over a Period of Time 19
Prominent Sponsors 20
Top Companies Participating in Retinitis Therapeutics Clinical Trials 22
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Neurotech Pharmaceuticals, Inc. 24
Clinical Trial Overview of Neurotech Pharmaceuticals, Inc. 24
Pfizer Inc. 25
Clinical Trial Overview of Pfizer Inc. 25
Isis Pharmaceuticals, Inc. 26
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 26
Allergan, Inc. 27
Clinical Trial Overview of Allergan, Inc. 27
Johnson & Johnson 28
Clinical Trial Overview of Johnson & Johnson 28
Clinical Trial Overview of Top Universities / Institutes / Hospitals 29
National Neurovision Research Institute 29
Clinical Trial Overview of National Neurovision Research Institute 29
Azienda Policlinico Umberto I 30
Clinical Trial Overview of Azienda Policlinico Umberto I 30
Tehran University of Medical Sciences 31
Clinical Trial Overview of Tehran University of Medical Sciences 31
Semmelweis University 32
Clinical Trial Overview of Semmelweis University 32
University of Sao Paulo 33
Clinical Trial Overview of University of Sao Paulo 33
National Taiwan University Hospital 34
Clinical Trial Overview of National Taiwan University Hospital 34
Sheba Medical Center 35
Clinical Trial Overview of Sheba Medical Center 35
Johns Hopkins University 36
Clinical Trial Overview of Johns Hopkins University 36

Appendix 37
Abbreviations 37
Definitions 37
Research Methodology 38
Secondary Research 38
About GlobalData 39
Contact Us 39
Disclaimer 39
Source 39

List of Tables


Retinitis Therapeutics Market, Global, Clinical Trials by Zone, 2011* 6
Retinitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 7
Retinitis Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 8
Retinitis Therapeutics Clinical Trials, Asia-Pacific , Top Countries, 2011* 9
Retinitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 10
Retinitis Therapeutics Clinical Trials, North America, Top Countries, 2011* 11
Retinitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 12
Retinitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2011* 13
Retinitis Therapeutics Clinical Trials, BRIC Countries, 2011* 14
Retinitis Therapeutics Market, Global, Clinical Trials by Phase, 2011* 15
Retinitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 16
Retinitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Retinitis Therapeutics Market, Global, Terminated Clinical Trials, 2011* 18
Retinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Retinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Retinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 22
Retinitis Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011* 23
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurotech Pharmaceuticals, Inc., 2011* 24
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 25
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2011* 26
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2011* 27
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011* 28
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Neurovision Research Institute, 2011* 29
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Policlinico Umberto I, 2011* 30
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2011* 31
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Semmelweis University, 2011* 32
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2011* 33
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011* 34
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2011* 35
Retinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2011* 36

List of Figures


Retinitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 6
Retinitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 7
Retinitis Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 8
Retinitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011* 9
Retinitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 10
Retinitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 12
Retinitis Therapeutics Clinical Trials, BRIC Countries (%), 2011* 14
Retinitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 15
Retinitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 16
Retinitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Retinitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Retinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 20
Retinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 22
Retinitis Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011* 23
GlobalData Methodology 38

Upcoming Reports:

DNA Sequencing Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
The global DNA sequencing market is forecast to grow to $6.6 billion over the year 2016 at the compounded annual growth rate of 17.5% as a result of emerging technologies in this field and its use in a number of applications.   DNA sequencing industry is segmented into instruments and consumables, services, and workflow products. Instruments and consumables segment are the rapidly emerging segments accounting for about $2.2 billion by the year 2016. Services segment is expected to grow significantly and reach market value of $3.5 billion with CAGR of 29% over the year 2016....
Global Vaccine Market Analysis and Forecast 2011-2016
By - Transparency Market Research
The report contains the global scenario of Vaccine market discussing its details and market figures. The report provides market size and forecast till 2016 for each segment and geography across the globe. It also describes the key influencing factors for the global vaccine market.  The report lists mergers & acquisitions among the major players along with key product developments in the market. The report also provides information about major players in the market as company profiles. Market Overview : The massive growth in the vaccine market globally...
Industrial Sludge Treatment Chemicals Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2012 - 2018
By - Transparency Market Research
Industrial sludge treatment chemicals are the formulations used for treating waters which are polluted by harmful industrial chemicals or by commercial activities, prior to the waters’ re-use or release into the environment. The end-users of these chemicals are all the industries that produce harmful sludge such as mining processing chemicals, iron and steel industries, mines and quarries, food industries, complex organic chemicals industries, nuclear industries and water treatment industries. Industrial sludge treatment chemicals have various applications which include...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...